ProQR Therapeutics N.V. PRQR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 133.81M | 93.49M | 108.50M | 125.41M | 140.65M |
| Total Receivables | 2.13M | 3.13M | 5.97M | 2.99M | 2.85M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.02M | 3.66M | 3.08M | 2.23M | 2.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 138.96M | 100.29M | 117.56M | 130.62M | 145.95M |
|
|
|||||
| Total Current Assets | 138.96M | 100.29M | 117.56M | 130.62M | 145.95M |
| Net Property, Plant & Equipment | 13.62M | 13.90M | 14.83M | 15.27M | 15.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 152.58M | 114.19M | 132.39M | 145.90M | 161.52M |
|
|
|||||
| Total Accounts Payable | -- | 217.90K | 349.90K | 357.90K | 1.51M |
| Total Accrued Expenses | 244.50K | -- | -- | 142.00K | 330.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.56M | 7.68M | 7.53M | 7.60M | 7.49M |
| Total Finance Division Other Current Liabilities | 32.03M | 32.52M | 30.21M | 30.78M | 29.53M |
| Total Other Current Liabilities | 32.03M | 32.52M | 30.21M | 30.78M | 29.53M |
| Total Current Liabilities | 39.84M | 40.42M | 38.09M | 38.88M | 38.86M |
|
|
|||||
| Total Current Liabilities | 39.84M | 40.42M | 38.09M | 38.88M | 38.86M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.93M | 10.46M | 11.21M | 11.75M | 12.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.01M | 19.96M | 25.12M | 28.31M | 31.69M |
| Total Liabilities | 61.78M | 70.84M | 74.42M | 78.94M | 82.86M |
|
|
|||||
| Common Stock & APIC | 613.95M | 562.88M | 573.19M | 572.79M | 573.33M |
| Retained Earnings | -556.85M | -552.17M | -548.91M | -538.20M | -525.86M |
| Treasury Stock & Other | 33.70M | 32.63M | 33.69M | 32.37M | 31.20M |
| Total Common Equity | 90.80M | 43.35M | 57.97M | 66.96M | 78.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.80M | 43.35M | 57.97M | 66.96M | 78.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 90.80M | 43.35M | 57.97M | 66.96M | 78.66M |
|
|
|||||